Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate combined with febuxostat versus benzbromarone for gout with hypertriglyceridemia
ChiCTR1800018160Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fenofibrate, febuxostat and benzbromarone in gout and hypertriglyceridemia (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: serum uric acid at Week 14. Started Sep 2018; status: recruiting.
02
Drugs
fenofibratefebuxostatbenzbromarone
03
Conditions
gouthypertriglyceridemia
Beyond the preview
Go deeper on ChiCTR1800018160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018160.